WuXi Biologics

WuXi Biologics is a leading global contract research, development, and manufacturing organization (CRDMO) for biologics. The company provides end-to-end solutions from antibody discovery to commercial manufacturing. Listed on the Hong Kong Stock Exchange, WuXi Biologics operates facilities across China, Ireland, Germany, Singapore, and the US, and is a critical node in the global pharmaceutical supply chain. The company has been at the center of geopolitical discussions around biotech supply chain security.

药明生物是全球领先的CDMO，赋能生物制剂的发现、开发和制造，服务全球超过600家客户，拥有全球最大的一次性生物反应器产能之一。